Schedule 13G ownership disclosure

AERIE PHARMACEUTICALS INC

Security class unavailable · CUSIP: 00771V108

Event date: 2017-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,698,419
Percent of class
10.1900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000561
Form type
SC 13G/A
Filer
AERIE PHARMACEUTICALS INC
CIK
CIK 1337553
Filed
Aug 10, 2017
Reporting period
Jul 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub